News Archives

Peripheral Nerve Stimulation Pioneer Dr. Marc Huntoon Joins SPR Therapeutics as Director of Medical Affairs

August 2, 2022

Cleveland, Ohio – August 2, 2022 – SPR Therapeutics is proud to announce the addition of Dr. Marc Huntoon to the company as Director of Medical Affairs. In this role, he will provide insight to …

Category: News

SPR Therapeutics to Present Clinical Trial and Real-World Findings at ASPN 2022

July 14, 2022

Cleveland, Ohio – July 14, 2022- SPR Therapeutics announced today that two presentations highlighting SPRINT® PNS in treating chronic pain will be featured at the American Society of Pain & …

Category: News

SPR Therapeutics Named a Top Workplace

June 26, 2022

– Selection based on employee satisfaction and engagement – Cleveland, Ohio – June 26, 2022 – SPR Therapeutics has been awarded a Top Workplaces 2022 honor by cleveland.com and The Plain …

Category: News

Real-World Evidence of Significant and Sustained Outcomes Following 60-Day Peripheral Nerve Stimulation Treatment for Chronic Pain

June 1, 2022

Real-world evidence (RWE), derived from analysis of data from the routine use of a treatment or therapy in general clinical practice, has an important role in providing insight into treatment …

Category: NewsTag: 60-day percutaneous PNS, Chronic Pain, PNS, SPRINT PNS, SPRINT PNS System

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Peripheral Nerve Stimulation Pioneer Dr. Marc Huntoon Joins SPR Therapeutics as Director of Medical Affairs

SPR Therapeutics to Present Clinical Trial and Real-World Findings at ASPN 2022

SPR Therapeutics Named a Top Workplace

Real-World Evidence of Significant and Sustained Outcomes Following 60-Day Peripheral Nerve Stimulation Treatment for Chronic Pain

SPR® Therapeutics Named #1 on Crain’s Cleveland Business Fast 50 list

SPR® Therapeutics Debuts New SPRINT® PNS Data for Low Back, Shoulder, Knee, and Headache at the 23rd Annual ASRA Pain Medicine Meeting

Ben Austin, CFO and COO of SPR® Therapeutics, Named to Crain’s Cleveland Business 40 Under 40 List

SPR Therapeutics Founder and CEO Maria Bennett on managing pain with nerve stimulation, not drugs: Women Who Lead